Breaking News, Collaborations & Alliances

PharmaZell and Novasep Merge to Create CDMO and API Manufacturer

Combining the two businesses will create a global company with a footprint in Europe, the U.S. and India.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Active pharmaceutical ingredient (API) supplier PharmaZell, and Novasep, a contract development and manufacturing organization (CDMO) focused on complex small molecules and ADCs, are merging following negotiations initiated in September 2021. This deal creates a technology driven, leading CDMO and API manufacturer. Novasep’s assets, capabilities, experience and expertise are complementary to those of PharmaZell. Combining the two businesses will create a global company with a footprint in Eur...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters